alexa Abstract | Discovery of Check Point Kinase 1 (Chk1) Inhibitors as Potential Anticancer Agents Using Ligand-Based Modelling and Virtual Screening

Journal of In Silico & In Vitro Pharmacology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Check point kinase 1 (Chk1) is an important protein in the G2 phase required by cancer cells to maintain cell cycle and to prevent cell death. Accordingly, inhibitors of this kinase should have potent anti-cancer properties. Pharmacophoric space of 190 Chk1 inhibitors using seven diverse sets of inhibitors was explored to identify high-quality pharmacophores. Subsequently, genetic algorithm-based quantitative structure activity relationship (GA-QSAR) analysis was employed to select the best possible combination of pharmacophoric models and physicochemical descriptors that can explain bioactivity variation within the training inhibitors. Three successful orthogonal pharmacophores emerged in the optimum QSAR
equation (r2 152 = 0.54, r2 LOO= 0.52, F= 20.27, r2 PRESS against 38 test inhibitors = 0.50). The  QSAR-selected pharmacophores were validated using receiver operating characteristic (ROC) curve analyses. Moreover, the QSAR-selected pharmacophores describe binding interactions comparable to those seen in crystallographic structures of bound ligands within Chk1 binding pocket. The three pharmacophoric models and associated QSAR equation were applied to screen the national cancer institute (NCI) list of compounds. The captured hits were tested in vitro and new anti-Chk1 hits were discovered.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): AlShaer MA Khanfar MA Taha MO

Keywords

Check point kinase 1, Ligand based analysis, Serine-threonine kinase, Anticancer, Anti-inflammatory

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords